Cardlytics, Inc. Common Stock

As of June 30, 2026, Cardlytics, Inc. carries a market capitalization of 26.31M, placing it among publicly traded companies globally. Its enterprise value stands at 188.16M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cardlytics, Inc.'s next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, Cardlytics, Inc. has 5.81M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.14, and the price-to-book ratio stands at -1.64.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.05 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 188.16M versus a market cap of 26.31M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Cardlytics, Inc. maintains a current ratio of 1.62, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,186.50, indicating conservative leverage, while an interest coverage ratio of -5.92 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -33.66, reflecting losses generated across the asset base. The company generates approximately 560,835.03 in revenue per employee across its workforce of 319.75, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Cardlytics, Inc.'s stock has declined approximately 90.02% over the past 52 weeks. The 50-day moving average sits at 3.35, while the 200-day moving average is 6.73.

Over the twelve months ended June 30, 2026, Cardlytics, Inc. generated 179.33M in revenue and converted that into -100.28M in net income, yielding earnings per share of -18.77. EBITDA reached -65.99M, while operating income came in at -27.50M.

As of June 30, 2026, Cardlytics, Inc. holds 28.04M in cash and equivalents against 189.89M in total debt, resulting in a net debt position of 156.37M. Total book value stands at -16.00M, with working capital of 38.72M providing operational flexibility.

Cardlytics, Inc. produced 532,000.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -69,000.00 in capital expenditures, free cash flow totaled 463,000.00 - equivalent to 0.08 per share.

Over the twelve months ended June 30, 2026, Cardlytics, Inc. posted a gross margin of 47.93, reflecting its pricing power and cost economics. The operating margin of -15.34 and net profit margin of -55.92 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 1.86, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 118.32, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cardlytics, Inc. shareholders.

Cardlytics, Inc.'s most recent stock split took place on June 10, 2026 with a 10:1 split ratio.

As of June 30, 2026, Cardlytics, Inc. has an Altman Z-Score of -17.15, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.